Rituximab Treatment in Sjogren's Syndrome

Sponsor
University Medical Center Groningen
Study ID
NCT00363350
Phase
PHASE1/PHASE2
Status
Completed

Conditions

  • Sjogren's Syndrome

Eligibility Criteria

Sex
ALL
Age
18 Years - 85 Years
Healthy Volunteers
Not accepted

Interventions

Study Details

This study is an evaluation of the effect of rituximab compared to placebo in combination with steroids on salivary flow and serological and clinical parameters in patients with primary SS.

Key Dates

Start date
Aug 31, 2006
Status verified
Feb 2009
Primary completion
Oct 31, 2008
Completion
Oct 31, 2008

Study Design

Enrollment
30 participants (estimated)
Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Primary Outcome Measure

stimulated whole salivary flow rate [ Time Frame: 48 weeks ]

Related Studies